Ultragenyx (RARE)

Ultragenyx (RARE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.6B; returns 1 day -1.9%, 1 week +7.6%, 1 year -53.5%.

Ultragenyx Pharmaceutical Inc. (RARE) is a biopharmaceutical company focused on developing and commercializing therapies for rare and ultrarare genetic diseases. The company generates revenue primarily from its approved products targeting metabolic and neuromuscular disorders.

Groups RARE belongs to

• Biopharmaceutical
• Rare Diseases
• Biotechnology
• Healthcare
• Metabolic Disorders
• Commercial Stage Biotech
• Pharmaceuticals
• Gene Therapy
• Commercial Stage
• Life Sciences

RARE financial model: income statement, cash flow and balance sheet